The latest research from Fore Pharma, Europe Chronic Obstructive Pulmonary Disease Market and Competitive Landscape – 2020, provides comprehensive insights into Chronic Obstructive Pulmonary Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Chronic Obstructive Pulmonary Disease market size and drug sales. It also provides insights into Chronic Obstructive Pulmonary Disease epidemiology and late stage pipeline.
This research covers the following – Chronic Obstructive Pulmonary Disease treatment options, Chronic Obstructive Pulmonary Disease late stage clinical trials pipeline, Chronic Obstructive Pulmonary Disease prevalence by countries, Chronic Obstructive Pulmonary Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).
Research Scope:
– Countries: Germany, France, Italy, Spain, UK, Europe
– Chronic Obstructive Pulmonary Disease pipeline: Find out drugs in clinical trials for Chronic Obstructive Pulmonary Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Chronic Obstructive Pulmonary Disease epidemiology: Find out number of patients diagnosed (prevalence) with Chronic Obstructive Pulmonary Disease by countries
– Chronic Obstructive Pulmonary Disease drugs: Identify key drugs marketed and prescribed for Chronic Obstructive Pulmonary Disease by countries, including trade name, molecule name, and company
– Chronic Obstructive Pulmonary Disease drugs sales: Find out the sales value for Chronic Obstructive Pulmonary Disease drugs by countries
– Chronic Obstructive Pulmonary Disease market valuations: Find out the market size for Chronic Obstructive Pulmonary Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Chronic Obstructive Pulmonary Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Chronic Obstructive Pulmonary Disease drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Chronic Obstructive Pulmonary Disease market
– Develop in-depth knowledge of competition and markets
– Analyze Chronic Obstructive Pulmonary Disease drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Chronic Obstructive Pulmonary Disease market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Chronic Obstructive Pulmonary Disease Treatment Options
2. Chronic Obstructive Pulmonary Disease Pipeline Insights
2.1. Chronic Obstructive Pulmonary Disease Phase 3 Clinical Trials
2.2. Chronic Obstructive Pulmonary Disease Phase 2 Clinical Trials
2.3. Chronic Obstructive Pulmonary Disease Phase 1 Clinical Trials
3. Chronic Obstructive Pulmonary Disease Epidemiology Analysis by Countries
4. Germany Chronic Obstructive Pulmonary Disease Market Insights
4.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Germany
4.2. Germany Chronic Obstructive Pulmonary Disease Market Size & Forecast
4.3. Germany Chronic Obstructive Pulmonary Disease Drugs Sales Forecast
4.4. Germany Chronic Obstructive Pulmonary Disease Market Share Analysis
5. France Chronic Obstructive Pulmonary Disease Market Insights
5.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in France
5.2. France Chronic Obstructive Pulmonary Disease Market Size & Forecast
5.3. France Chronic Obstructive Pulmonary Disease Product Sales Forecast
5.4. France Chronic Obstructive Pulmonary Disease Market Share Analysis
6. Italy Chronic Obstructive Pulmonary Disease Market Insights
6.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Italy
6.2. Italy Chronic Obstructive Pulmonary Disease Market Size & Forecast
6.3. Italy Chronic Obstructive Pulmonary Disease Product Sales Forecast
6.4. Italy Chronic Obstructive Pulmonary Disease Market Share Analysis
7. Spain Chronic Obstructive Pulmonary Disease Market Insights
7.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Spain
7.2. Spain Chronic Obstructive Pulmonary Disease Market Size & Forecast
7.3. Spain Chronic Obstructive Pulmonary Disease Product Sales Forecast
7.4. Spain Chronic Obstructive Pulmonary Disease Market Share Analysis
8. UK Chronic Obstructive Pulmonary Disease Market Insights
8.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in UK
8.2. UK Chronic Obstructive Pulmonary Disease Market Size & Forecast
8.3. UK Chronic Obstructive Pulmonary Disease Product Sales Forecast
8.4. UK Chronic Obstructive Pulmonary Disease Market Share Analysis
9. Europe Chronic Obstructive Pulmonary Disease Market Insights
9.1. Europe Chronic Obstructive Pulmonary Disease Market Size & Forecast
9.2. Europe Chronic Obstructive Pulmonary Disease Product Sales Forecast
9.3. Europe Chronic Obstructive Pulmonary Disease Market Share Analysis
10. Research Methodology
List of Tables
1: Chronic Obstructive Pulmonary Disease Phase 3 Clinical Trials, Global, 2020
2: Chronic Obstructive Pulmonary Disease Phase 2 Clinical Trials, Global, 2020
3: Chronic Obstructive Pulmonary Disease Phase 1 Clinical Trials, Global, 2020
4: Chronic Obstructive Pulmonary Disease Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Germany, 2019
6: Germany Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 – 2025
7: Germany Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
8: Germany Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Chronic Obstructive Pulmonary Disease in France, 2019
10: France Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 – 2025
11: France Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
12: France Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Italy, 2019
14: Italy Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 – 2025
15: Italy Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
16: Italy Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Spain, 2019
18: Spain Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 – 2025
19: Spain Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
20: Spain Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Chronic Obstructive Pulmonary Disease in UK, 2019
22: UK Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 – 2025
23: UK Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
24: UK Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 – 2025
25: Europe Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 – 2025
26: Europe Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
List of Figures
1: Chronic Obstructive Pulmonary Disease Pipeline by Phase (%), Global, 2020
2: Chronic Obstructive Pulmonary Disease Prevalence by Countries, 2016 – 2025
3: Germany Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 – 2025
4: Germany Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
5: Germany Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
6: Germany Chronic Obstructive Pulmonary Disease Market – Future Market Share (%), 2025
7: France Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 – 2025
8: France Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
9: France Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
10: France Chronic Obstructive Pulmonary Disease Market – Future Market Share (%), 2025
11: Italy Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 – 2025
12: Italy Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
13: Italy Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
14: Italy Chronic Obstructive Pulmonary Disease Market – Future Market Share (%), 2025
15: Spain Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 – 2025
16: Spain Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
17: Spain Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
18: Spain Chronic Obstructive Pulmonary Disease Market – Future Market Share (%), 2025
19: UK Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 – 2025
20: UK Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
21: UK Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
22: UK Chronic Obstructive Pulmonary Disease Market – Future Market Share (%), 2025
23: Europe Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 – 2025
24: Europe Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 – 2025
25: Europe Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
26: Europe Chronic Obstructive Pulmonary Disease Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.